UNSPSC 51284909: Phenazopyridine/sulfisoxazole

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM650. This VA Drug Class (AM650) classifies this compound as belonging to the group SULFONAMIDE/RELATED ANTIMICROBIALS.

UNSPSC 51284909 Phenazopyridine/sulfisoxazole is a Commodity code for pharmaceutical products, though recent state and local solicitations tagged under this code show limited direct alignment with the specific drug named. The source material reveals activity that includes broader pharmaceutical procurement — notably antibiotics and emergency medical supplies — rather than phenazopyridine/sulfisoxazole products specifically. State and local issuing bodies acquiring products under this code include health departments and county community health agencies, typically buying through piggyback cooperative purchasing vehicles and competitive invitation-for-bid processes. The Illinois Department of Public Health has used MMCAP Infuse consortium piggyback contracts for pharmaceutical warehouse supply, while Seminole County, Florida procures emergency medical products including naloxone for community health initiatives.

Recent opportunities span Florida and Illinois. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (Bid 26-482DPH-PREPD-B-53392) for antibiotics including Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets, with a total contract value of $2,999,999.11 over three years and an initial 12-month term. Seminole County, Florida issued an IFB (IFB60459723LAS) posted June 30, 2026 with a July 26, 2026 response deadline for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a two-year initial term plus one-year renewal option. Neither opportunity directly matched the code's nominal scope, suggesting that the code shows limited recent activity tied specifically to phenazopyridine/sulfisoxazole procurement.